ZURA

Zura Bio (ZURA)

About Zura Bio (ZURA)

Zura Bio Ltd. is a clinical-stage, multi-asset immunology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Details

Daily high

$6.01

Daily low

$5.72

Price at open

$5.78

52 Week High

$7.44

52 Week Low

$1.39

Market cap

542.4M

Dividend yield

0.00%

Volume

955,899

Avg. volume

649,959

P/E ratio

-4.68

Zura Bio News